Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
about
The Genetics of Nephrotic Syndrome.Ultrastructural Characterization of the Glomerulopathy in Alport Mice by Helium Ion Scanning Microscopy (HIM).Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome.Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane.Speech, language, and hearing function in twins with Alport syndrome: A seven-year retrospective case report.
P2860
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@ast
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@en
Pathology vs. molecular genetics:
@nl
type
label
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@ast
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@en
Pathology vs. molecular genetics:
@nl
prefLabel
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@ast
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@en
Pathology vs. molecular genetics:
@nl
P2860
P356
P1433
P1476
Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome.
@en
P2093
Jeffrey H Miner
P2860
P2888
P304
P356
10.1038/KI.2014.326
P407
P577
2014-12-01T00:00:00Z
P5875
P6179
1000562956